Curtis R. Pickering, Ph.D.
Affiliations: | 2008 | Cell Biology | University of California, San Francisco, San Francisco, CA |
Area:
Oncology, Cell BiologyGoogle:
"Curtis Pickering"Parents
Sign in to add mentor| Thea D. Tlsty | grad student | 2008 | UCSF | |
| (Understanding the early events in breast carcinogenesis by inactivating p16INK4a in primary human mammary epithelial cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Abdelhakiem MK, Bao R, Pifer PM, et al. (2024) Th2 Cells Are Associated with Tumor Recurrence Following Radiation. Cancers. 16 |
| Gleber-Netto FO, Nagarajan P, Sagiv O, et al. (2024) Histologic and Genomic Analysis of Conjunctival SCC in African and American Cohorts Reveal UV Light and HPV Signatures and High Tumor Mutation Burden. Investigative Ophthalmology & Visual Science. 65: 24 |
| Zhao M, Wang T, Gleber-Netto FO, et al. (2024) Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response. Nature Communications. 15: 180 |
| Pifer PM, Yang L, Kumar M, et al. (2023) FAK drives resistance to therapy in HPV-negative head and neck cancer in a p53-dependent manner. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Coleman N, Marcelo KL, Hopkins JF, et al. (2023) Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma. Jco Precision Oncology. 7: e2200211 |
| Chahoud J, Zacharias NM, Pham R, et al. (2022) Prognostic Significance of p16 and Its Relationship with Human Papillomavirus Status in Patients with Penile Squamous Cell Carcinoma: Results of 5 Years Follow-Up. Cancers. 14 |
| Callahan SC, Kochat V, Liu Z, et al. (2022) High enhancer activity is an epigenetic feature of HPV negative atypical head and neck squamous cell carcinoma. Frontiers in Cell and Developmental Biology. 10: 936168 |
| Shi Y, Xie T, Wang B, et al. (2022) Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma. Communications Biology. 5: 757 |
| Molkentine DP, Molkentine JM, Bridges KA, et al. (2021) p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade. Cancer Research |
| Gorur A, Patiño M, Shi T, et al. (2021) Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor. Journal of Cellular Physiology |